Literature DB >> 18771740

Unique membrane-interacting properties of the immunostimulatory cationic peptide KLKL(5)KLK (KLK).

Michael C Aichinger1, Martina Ortbauer, Siegfried Reipert, Wolfgang Zauner, Péter Bogner, Elisabeth Froschauer, Karin Nowikovsky, Karen Lingnau, Alexander von Gabain, Rudolf Schweyen, Tamás Henics.   

Abstract

We have monitored the effects of KLKL(5)KLK (KLK), a derivative of a natural cationic antimicrobial peptide (CAP) on isolated membrane vesicles, and investigated the partition of the peptide within these structures. KLK readily interacted with fluorescent dyes entrapped in the vesicles without apparent pore formation. Fractionation of vesicles revealed KLK predominantly in the membrane. Peptide-treated vesicles appeared with generally disorganized bilayers. While KLK showed no effect on osmotic resistance of human erythrocytes, dramatic decrease in core and surface membrane fluidity was observed in peptide-treated erythrocyte ghosts as measured by fluorescence anisotropy. Finally, CD spectroscopy revealed lipid-induced random coil to beta-sheet and beta-sheet to alpha-helix conformational transitions of KLK. Together with the oligonucleotide oligo-d(IC)(13) [ODN1a], KLK functions as a novel adjuvant, termed IC31. Among other immunological effects, KLK appears to facilitate the uptake and delivery of ODN1a into cellular compartments, but the nature of KLK's interaction with the cell surface and other membrane-bordered compartments remains unknown. Our results suggest a profound membrane interacting property of KLK that might contribute to the immunostimulatory activities of IC31.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18771740     DOI: 10.1016/j.cellbi.2008.08.024

Source DB:  PubMed          Journal:  Cell Biol Int        ISSN: 1065-6995            Impact factor:   3.612


  3 in total

1.  Cationic amphipathic peptides accumulate sialylated proteins and lipids in the plasma membrane of eukaryotic host cells.

Authors:  Julian Weghuber; Michael C Aichinger; Mario Brameshuber; Stefan Wieser; Verena Ruprecht; Birgit Plochberger; Josef Madl; Andreas Horner; Siegfried Reipert; Karl Lohner; Tamás Henics; Gerhard J Schütz
Journal:  Biochim Biophys Acta       Date:  2011-06-28

2.  Therapeutic approaches using host defence peptides to tackle herpes virus infections.

Authors:  Håvard Jenssen
Journal:  Viruses       Date:  2009-11-18       Impact factor: 5.048

3.  The two-component adjuvant IC31® boosts type i interferon production of human monocyte-derived dendritic cells via ligation of endosomal TLRs.

Authors:  Attila Szabo; Peter Gogolak; Kitti Pazmandi; Katalin Kis-Toth; Karin Riedl; Benjamin Wizel; Karen Lingnau; Attila Bacsi; Bence Rethi; Eva Rajnavolgyi
Journal:  PLoS One       Date:  2013-02-06       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.